Ranging from Greek mythology to the Sixties, this contribution analyses

the social, scientific and anthropological reasons that led to the desertion of the delivery vertical position in favour of the lying down one.”
“A fungal strain named YLF-14 was isolated from the leaf of Altingia yunnunensis. Based on the sequence at the internal transcribed spacer (ITS) region, the strain was identified as an Aspergillus sp.. A new sesquiterpene 5 beta,8a beta-dimethyl-3,4,4a beta,5,6,7,8,8a-octahydronaphthalene-1,2,5 alpha-trimethanol (1) and a known compound 12-N-methylcyclo-(L-tryptophyl-L-phenylalanyl) (2) were isolated from the culture of this strain. Bioassay experiments showed that the two compounds had no obvious effect SB273005 selleck chemicals on the growth of tested bacteria and nematodes.”
“Ethylacetate and butanol fractions of leaf extracts (OLE) showed the higher contents of total phenolic compounds than hexane and water fractions. Oleuropein contents

were 4.21 +/- 0.57, 3.92 +/- 0.43, 0.32 +/- 0.03, 5.76 +/- 0.32, and 32.47 +/- 0.25 mg/100 g for ethanol extract, and hexane, chloroform, ethyl acetate, and butanol fraction, respectively. Treatment of ultraviolet-B (UVB) irradiated cells with 3 OLEs prepared by using ethylacetate and butanol at concentrations 0.001, 0.005, and 0.01% respectively showed significant recover), of cell viabilities. Treatment of dexametason 1 mM reduced tumor necrotic factor (TNF)-alpha secretion by about 40%. UVB irradiated immortalized human keratinocytes (HaCaT) cells were treated with 3 different OLEs at the same concentrations. Ethylacetate fraction showed the strongest inhibition activity with respect of reduction of the elevated TNF-alpha. Cytotoxicity

of OLEs on the B16-F1 cells was evaluated through thiazolyl blue tetrazolium bromide (MTT) assay. Ethylacetate fraction has no cytotoxicity in the range of 0.005-0.01%. A slight cytotoxicity was observed at the concentration of 0.1% butanol fraction of OLE that caused 10% decrease in cell viability.”
“Objective: Human Cytomegalovirus Rho inhibitor (CMV) infection during pregnancy is the most frequent viral cause of intrauterine infection and responsible for various cerebral and other ultrasound abnormalities of the fetus. It is the leading infectious cause of mental retardation and sensorineural deafness in affected newborns and infants.

We present three cases of primary cytomegalovirus infection in pregnancy and demonstrate three different scenarios of the disease with regard to clinical outcome and therapy options. We first report on CMV related phospho-and glycoprotein-specific antibody reactivities in amnion fluid that have not been reported earlier in literature.

Case presentation: Case 1: A 33-year-old Gravida II Para I was referred for primary CMV infection at 15 weeks gestation presenting with a history of fever.